Product Information
ARFORMOTEROL 15 MCG/2 ML SOLN is a generic product labeled by Cipla USA Inc., priced at $0.6202 per ML under NDC 69097016864. Its NADAC has been published 268 times since Aug 18, 2021.
FDA first approved this application on Jun 22, 2021. Its Orange Book therapeutic-equivalence code is AN.
The High Outlier badge above means this manufacturer's average price in the arformoterol tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 ug/2mL
Manufacturer
Cipla USA Inc.NDC
69097016864
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ARFORMOTEROL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207306FDA Approved
6/22/2021
TE Code
AN
On Market Since
6/22/2021
Pharmacological Classes
Price Statistics
The NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has been published 268 times since Aug 18, 2021, and over the history we have for it it has declined 92.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6202 per ML |
|---|---|
| All-time high | $7.7537 (Sep 15, 2021) |
| All-time low | $0.6202 (Sep 23, 2026) |
| 52-week high | $0.7666 |
| 52-week low | $0.6202 |
| Median price | $1.3006 |
| Average price | $1.6417 |
| Largest weekly change | -58.7% (Sep 22, 2021) |
| Weeks tracked | 268 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
arformoterol tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARFORMOTEROL 15 MCG/2 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for ARFORMOTEROL 15 MCG/2 ML SOLN, manufactured by Cipla USA Inc., is $0.6202 per ML (NDC 69097016864), effective Sep 30, 2026.
How has the price of ARFORMOTEROL 15 MCG/2 ML SOLN changed over time?
Over the history we have for it, the NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has declined 92.0%. It has been tracked across 268 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for ARFORMOTEROL 15 MCG/2 ML SOLN?
Since Aug 18, 2021, the NADAC for ARFORMOTEROL 15 MCG/2 ML SOLN has ranged from a low of $0.6202 (Sep 23, 2026) to a high of $7.7537 (Sep 15, 2021), with a median of $1.3006 per ML.
Are there cheaper alternatives to ARFORMOTEROL 15 MCG/2 ML SOLN?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ARFORMOTEROL 15 MCG/2 ML SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures ARFORMOTEROL 15 MCG/2 ML SOLN?
ARFORMOTEROL 15 MCG/2 ML SOLN (NDC 69097016864) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.